Medicines recalled
On March 10, 2026, the Health and Labor Inspection Body issued a directive to “ARGO-PHARM” Limited Liability Company to cease the circulation of batch 031025 of the drug “Baclofen-Usolye 25 mg” and to initiate its recall.
The recall pertains to “Baclofen-Usolye 25 mg” (50/5×10) tablets in blisters, manufactured by “Usolye-Sibirsky Chemical and Pharmaceutical Plant” OJSC in Russia. The expiration date for the specified batch is set for October 2028.
The directive is based on letter No. 03/1274-26 and the attached expert conclusion submitted on March 10, 2026, by the “Scientific Centre of Drug and Medical Technology Expertise” SNCO.
During laboratory testing, non-compliances requiring correction were identified regarding the criteria for detecting related impurities according to specification requirements. Specifically, “Unknown impurity 1” was recorded, and the total amount of unknown impurities was found to exceed the permitted limits.
Due to these circumstances, a decision was made to suspend the circulation of this batch of the drug and to implement its recall from the market.
The Inspection Body urges citizens to be vigilant and avoid using batch 031025 of the drug “Baclofen-Usolye 25 mg.”
